Cytek Biosciences, Inc. CTKB Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s quick ratio?
- Cytek Biosciences, Inc. (CTKB) reported quick ratio of 4.1× in Q1 2026.
- How has Cytek Biosciences, Inc.'s quick ratio changed year-over-year?
- Cytek Biosciences, Inc.'s quick ratio decreased by 17.8% year-over-year, from 5× to 4.1×.
- What is the long-term trend for Cytek Biosciences, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s quick ratio has grown at a -8.8% compound annual growth rate (CAGR), from 7× to 4.4×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.